Anticancer Effects of ZnO/CNT@Fe(3)O(4 )in AML-Derived KG1 Cells: Shedding Light on Promising Potential of Metal Nanoparticles in Acute Leukemia

Background: Therapeutic approaches for acute myeloid leukemia (AML) have remained largely unchanged for over 40 years and cytarabine and an anthracycline (e.g., daunorubicin) backbone is the main induction therapy for these patients. Resistance to chemotherapy is the major clinical challenge and con...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousefi, Amir-Mohammad, Pourbagheri-Sigaroodi, Atieh, Fakhroueian, Zahra, Salari, Sina, Fateh, Kosar, Momeny, Majid, Bashash, Davood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831873/
https://www.ncbi.nlm.nih.gov/pubmed/36694699
http://dx.doi.org/10.18502/ijhoscr.v16i3.10136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831873/
https://www.ncbi.nlm.nih.gov/pubmed/36694699
http://dx.doi.org/10.18502/ijhoscr.v16i3.10136

Ejemplares similares